June 4, 2009 Marketing Trumps Safety: the case of AntipsychoticsJust as the FDA is convening an advisory committee hearing (June 9-10) about whether to expand the Read More Marketing Trumps Safety: the case of Antipsychotics
May 8, 2009 Has the Obama administration already cowered to the demands of Big Pharma?The unexpected approval of a "me too" dangerous antipsychotic drug that the agency itself had deemed "NOT Read More Has the Obama administration already cowered to the demands of Big Pharma?
May 7, 2009 Title: FDA Approves Antipsychotic With Long History of Failure"Hoechst Marion Roussel Inc. made initial inquiries into the drug; however, in May 1996, they discontinued research, Read More Title: FDA Approves Antipsychotic With Long History of Failure
March 30, 2009 Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildrenThe State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being Read More Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildren
November 24, 2008 Biederman J & J Risperdal DocumentsA group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing Read More Biederman J & J Risperdal Documents
November 24, 2008 Biederman J & J Risperdal DocumentsThe New York Times reports (below) "Dr. Biederman’s work helped to fuel a 40-fold increase from 1994 Read More Biederman J & J Risperdal Documents
November 18, 2008 Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle ApproachThe New York Times reports that an FDA advisory committee deliberating over the safety of using antipsychotic Read More Antipsychotic Use in Children: FDA Panel Rejects FDA Soft-Peddle Approach
November 30, 2007 Letter of Complaint to FDA Commissioner, 2007 ALLIANCE FOR HUMAN RESEARCH PROTECTION www.ahrp.org 142 West End Avenue, Suite 28P New York, NY Read More Letter of Complaint to FDA Commissioner, 2007
February 25, 2007 Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by ZyprexaEvelyn Pringle reports (below) that the group is also supporting Jim Gottstein in his battle with Eli Read More Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa
January 12, 2007 Pfizer CEO Urges Staff to Mobilize & Lobby Congress Against Drug Price ControlsBelow is a case example of the collision between Big Pharma and the American consumer. The New Read More Pfizer CEO Urges Staff to Mobilize & Lobby Congress Against Drug Price Controls
December 19, 2006 Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label UseThe New York Times reports (below) that additional state Attorneys General are demanding that Eli "Lilly hand Read More Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label Use
December 18, 2006 AHRQ No Evidence to Support Off-Label Uses of Atypical AntipsychoticsA new federally funded study by HHS Agency for Healthcare Research andQuality, found little or no evidence Read More AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics
December 5, 2006 Assaultive Prescribing of Psych Drugs for ChildrenSuffer the little children for the drug companies and their duly financially awarded physicians, patient “advocacy” groups Read More Assaultive Prescribing of Psych Drugs for Children
December 1, 2006 New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPostThe second phase of the government study, Clinical Antipsychotic Trials inIntervention Effectiveness (CATIE), was released and the Read More New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost